Brokerages have given Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) a consensus recommendation of “Moderate Buy.”
According to the data made available by Bloomberg.com, the seven brokerages that provide coverage for Calumet Specialty Products Partners, L.P. ...